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Abstract
Purpose To investigate the eVect of pregestational maternal,
obstetric and perinatal factors on neonatal outcome in
extreme preterm deliveries.
Methods Retrospective study of deliveries in a Norwegian
tertiary teaching hospital. All women with live births at
24+0– 27+6 weeks of gestation between 2004 and 2007 were
included. Major morbidity is deWned as intraventricular
haemorrhage grade 3–4, periventricular leukomalacia,
bronchopulmonary dysplasia or necrotizing enterocolitis.
Pregestational maternal, obstetric and perinatal variables
were initially compared for mortality and survival with
major morbidity at 24-h, 7- or 28-day postpartum/discharge
in univariate analysis. Then, a multivariate analysis was
conducted in order to determine independent factors associ-
ated with mortality and survival with major morbidity.
Results A total of 109 babies were delivered alive in 92
women, representing 1.6% of total births. The survival rates
were 93.6, 84.4 and 80.7%, with a prevalence of major
morbidity among survivors of 40.4, 32.1 and 39.4% at 24-h,
7- and 30-day postpartum/discharge, respectively. After
adjustment using multiple logistic regression, only a 5-min
Apgar score ·3 and babies with at least one major morbidity
had signiWcantly independent eVects on neonatal survival.
Multiple pregnancy and gestational age <26 weeks were
the only two independent risk factors for survival with
major morbidity.
Conclusions Neonatal survival was signiWcantly pre-
dicted by a 5-min Apgar score and neonatal morbidity,
independent of pregestational maternal disease, obstetric
complications, method of delivery, gestational age and
birth weight in extreme preterm deliveries. The excess mor-
bidity rate was conWned among multiples and babies who
were delivered before 26 weeks of gestation.
Keywords Extreme prematurity · Survival · Morbidity
Introduction
Despite eVorts directed towards prevention of preterm
birth, the incidence of prematurity and infants born with
very low birth weight (<1,500 g) in the USA has increased
from 10.6 and 1.27% in 1990 to 12.8 and 1.48% in 2006,
respectively [1]. In Norway, the incidence of prematurity
has increased from 5.2% in 1980 to 6.5% in 2007; however,
the percentage of extreme prematurity (between 22 and
27 weeks of gestation) has decreased from 0.5% in 1980 to
0.4% in 2007 (The Medical Birth Registry of Norway,
available at http://www.fhi.no). Preterm delivery, espe-
cially extreme prematurity and its short- and long-term
sequelae constitute a serious problem in terms of neonatal
and infant mortality, disability, and cost to society [2].
Wise et al. [3] concluded that neonatal mortality patterns in
the United States have become highly dependent on infants
with gestational ages that approach the second trimester
while very low birth weight infants (<1,500 g) account for
64.2% of all neonatal deaths. Advances in perinatal and
neonatal care in recent years, along with an increased
understanding of neonatal physiology, have greatly
improved the chances of survival of extremely low gesta-
tional age and low birth weight infants [4]. However, with
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extreme prematurity, most survivors experience signiWcant
morbidity and are at risk of long-term sequelae [5, 6] that
may aVect their quality of life as well as having major
economic implications both for their families and for
society [5]. Therefore, the survival outcome of extremely
premature newborns is no longer the principle marker of
success; long-term neurodevelopmental outcome has
become the most important indicator of a successful
outcome for infants born extremely premature.
There has been an eVort in recent times to identify
obstetric parameters as predictive factors of neonatal
mortality and morbidity in extreme prematurity. However,
few studies also include maternal and perinatal factors in
their analyses [7, 8]. The aim of the present study was to
investigate the eVect of pregestational maternal, obstetric
and perinatal factors on neonatal mortality and survival
with major morbidity in infants born between 24+0 and 27+6
weeks of gestation.
Materials and methods
This is a tertiary hospital-based retrospective analysis of all
live births with a gestational age of 24+0 to 27+6 weeks.
Birth registry records and neonatal records retrieved from
local databases at Oslo University Hospital Rikshospitalet,
Oslo, Norway between January 2004 and May 2007. Gen-
erally, women with a gestational age of 23+0 to 27+6 weeks
with threatened preterm delivery are transferred to Oslo
University Hospital Rikshospitalet from regional county
hospitals in south-east Norway. After 27+6 weeks of gesta-
tion, the infants can be delivered at the regional county
hospitals. All stillbirths were excluded. Infants delivered at
other hospitals and then subsequently admitted to the
Neonatal Intensive Care Unit (NICU) at Oslo University
Hospital Rikshospitalet were also excluded. All women
included in the present study were administered antenatal
steroid (Betametason 12 mg i.m.) before labour with two
doses spaced by 24 or 12 h. Antibiotics (Erythromycin
500 mg £ 4 p.o. or Penicillin G 1.2 g  £ 4 i.v. for 3 days)
were administered when indicated to women with signs of
infection, or as a prophylaxis to women with preterm pre-
mature rupture of membranes (pPROM), or before acute
caesarean section. Tocolytic therapy (atosiban three-step
infusion) was given to women with uterine contractions.
Gestational age was deWned as the number of completed
weeks of gestation based on screening ultrasound examina-
tion which was performed between gestational weeks 18–20 as
determined by the date of the last menstrual period. Neonatal
major morbidity was deWned as having at least one of the
following diagnoses: intraventricular haemorrhage grade
3–4 [9], periventricular leukomalacia, bronchopulmonary
dysplasia and necrotizing enterocolitis. Obstetric and
perinatal factors studied in relation to neonatal survival and
survival with major morbidity were maternal age, multiple
gestation, pre-eclampsia (blood pressure ¸140/90 mmHg
after 20 weeks gestation and a dipstick test for protein in
urine ¸+1 or total protein/creatine ratio in urine ¸30), ante-
partum haemorrhage (bleeding after 20 weeks gestation and
before labour), pPROM (the amniotic sac ruptures more
than an hour before the onset of labour before 37 weeks
gestation), oligohydramnios (amniotic Xuid index of less
than 5 cm), chorioamnionitis (presence of uterine tender-
ness and/or purulent or malodorous amniotic Xuid with any
two of the following: antepartum temperature of more than
38°C, maternal tachycardia >120 beats/min, maternal leuc-
ocytosis >18,000 cells/mm3, or fetal tachycardia >160
beats/min). Cervical insuYciency (recurrent second- or
early third-trimester fetal loss following painless cervical
dilatation), intrauterine growth restriction (IUGR, a
reduction in growth compared to the expected by a series
of measurements with ultrasound, at least two measure-
ments), delivery methods (vaginal birth vs. caesarean sec-
tion), 5-min Apgar score, birth weight, neonatal major
morbidity.
Pregestational maternal conditions (pulmonary stenosis,
hypertension, diabetes mellitus, unilateral renal agenesis,
hypothyreosis, asthma, Mb Chron disease, previous deep
vein thrombosis and rheumatoid arthritis), obstetric and
perinatal factors were initially compared for mortality
and survival with major morbidity at 24-h, 7- or 30-day
postpartum/discharge in univariate analysis using the
Chi-square test. Multiple binary logistic regression (backward
Wald model) was performed to determine independent risk
factors associated with mortality and survival with major
morbidity on outcome diVerences being signiWcant in
the univariate analysis. Survival or survival with major
morbidity was used as dependent factor, gestational age
<26 weeks, birth weight <800 g, Apgar score ·3 at 5 min,
survival with at least one major morbidity, multiple preg-
nancy and cervical insuYciency were used as covariate fac-
tors in the model for total survival. Gestational age
<26 weeks, multiple pregnancy, birth weight <800 g and
maternal age ¸35 years were used as covariate factors in
the model for survival with major morbidity. Statistical
analysis was performed using SPSS statistical program
version 16 (SPSS, Chicago, IL, USA). The statistical
signiWcance threshold was set to P · 0.05 (2-tailed). Odds
ratios (ORs) with 95% conWdence intervals (95% CI) were
calculated.
Results
A total of 132 infants were delivered in 109 women
between 24+0 and 27+6 weeks’ gestation during the studyArch Gynecol Obstet (2011) 284:1381–1387 1383
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period, representing 1.6% (109/6966) of total births.
Extreme prematurity rates among singletons were 1.3%
(89/6619) of the total births during the study period, while
the corresponding rate among multiple gestations was 5.8%
(20/347). 23 stillbirths were excluded, resulting in a total of
109 extremely premature newborns delivered by 92 women
included in the present study. All 109 infants were trans-
ferred to the NICU at Oslo University Hospital Rikshospi-
talet. Maternal characteristics and obstetrical complications
are presented in Table 1. In summary, 55.4% (51) were nul-
liparous and 19.6% (18) had diVerent pregestational
diseases. The three obstetric complications with highest fre-
quency were pPROM, pre-eclampsia and chorioamnionitis.
Neonatal survival at 28-day/discharge was 53.3% (8/15) for
delivery at 24 weeks, 76.7% (23/30) for 25 weeks, 90%
(27/30) for 26 weeks and 88.2% (30/34) for 27 weeks,
respectively. Caesarean section was performed in 60.9%
(56/92) of the cases, 26.7% (4/15) infants were delivered by
caesarean section at 24 weeks, 60% (18/30) at 25 weeks,
70% (21/30) at 26 weeks and 70.6% (24/35) at 27 weeks of
gestation, respectively. Major maternal and fetal indica-
tions for caesarean section were severe pre-eclampsia and
preterm breech presentation among singletons.
Table 2 summarizes perinatal characteristics and neona-
tal survival and major morbidity. 32.1% (35/109) infants
were born of multiple pregnancies and bronchopulmonary
dysplasia had the highest incident rates of 26.6% (29/109)
among major morbidities.
Table 3 shows the relation between total survival and
maternal, obstetric and perinatal characteristics in univari-
ate analysis. 24-h, 7- and 28-day/discharge survival was
signiWcantly lower in the group with birth weight <800 g
compared with birth weight ¸800 g, as well as in the group
with gestational age <26 weeks compared with gestational
age ¸26 weeks, with a 5-min Apgar score ·3 compared
Table 1 Maternal characteristic and obstetrical complication of
gestation
pPROM preterm premature rupture of membranes
n = 92 (%)
Maternal age ¸35 years 31 (33.7)
Primipara 51 (55.4)
Pregestational disease 18 (19.6) 
(21 complications)
Pulmonary stenosis 1
Hypertention 6
Diabetes mellitus type I or type II 3
Unilateral renal agenesis 1
Hypothyreosis 3
Asthma 3
Mb Chron disease 2
Previous deep vein thrombosis 1
Remaroid arthritis 1
Pre-eclampsia 21 (22.8)
Gestational diabetes mellitus 1 (1.1)
Cervical insuYciency 8 (8.7)
Antepartum haemorrhage 17 (18.5)
Oligohydramnion 6 (6.5)
pPROM 24 (26.1)
Chorioamnionitis 20 (21.7)
Placental abruption 10 (10.9)
Table 2 Perinatal characteristics and neonatal survival and major
morbidity
IUGR intrauterine growth restriction
n = 109 (%)
Gender
Male 58 (53.2)
Female 51 (46.8)
IUGR 19 (17.4)
Multiple pregnancy 45 (31.8)
Twins 25 (22.9)
Triplets 6 (5.5)
Quadruplets 4 (3.7)
Weeks of gestation
24+0–24+6 15 (13.8)
25+0–25+6 30 (27.5)
26+0–26+6 30 (27.5)
27+0–27+6 34 (31.2)
Birth weight (g)
<500 5 (4.6)
500–599 10 (9.2)
600–699 18 (16.5)
700–799 20 (18.3)
800–899 19 (17.4)
900–999 16 (14.7)
>1,000 21 (19.3)
Apgar score ·3 at 5 min 11 (10.1)
Survival postpartum
24-h 102 (93.6)
7-day 92 (84.4)
28-day/discharge 88 (80.7)
Survival with at least one major morbidity
24-h 44 (40.4)
7-day 35 (32.1)
28-day/discharge 32 (29.4)
Major morbidity (with at least one) 51 (46.8)
Intraventricular haemorrhage grade 3–4 17 (15.6)
Periventricular leukomalacia 5 (4.6)
Bronchopulmonary dysplasia 29 (26.6)
Necrotizing enterocolitis 5 (4.6)1384 Arch Gynecol Obstet (2011) 284:1381–1387
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with 5-min Apgar score >3 and in the group with at least
one major morbidity compared the babies without any mor-
bidity. Besides, 7- and 28-day/discharge survival were sig-
niWcantly lower in multiple pregnancies compared with
singletons.
Table 4 shows the relation between neonatal survival
with at least one major morbidity and maternal, obstetric
and perinatal characteristics in univariate analysis. 24-hour,
7- and 28-day/discharge survival with at least one major
morbidity were signiWcantly lower in the group with birth
weight <800 g compared with birth weight ¸800 g, in the
group with gestational age <26 weeks compared with ges-
tational age ¸26 weeks, and in multiple pregnancies com-
pared with singletons. Neonatal survival with at least one
major morbidity was not signiWcantly associated with pre-
gestational maternal disease, obstetric factors and method
of delivery, except that 7-day survival was signiWcantly
lower in the group with maternal age ¸35 years compared
with <35 years.
Multiple binary logistic regression was performed to
determine independent risk factors associated with mortal-
ity and survival with major morbidity. A 5-min Apgar score
·3 was the only independent risk factor for 24-h survival
(OR 136.7, 95% CI 11.6–1618.6). Because of a quasi-
complete separation (all 7 babies who died within 24 h
postpartum had at least one major complication), the
maximum likelihood estimates do not exist for 24-h sur-
vival for babies with at least one major morbidity in multi-
ple logistic regression analysis. Both the 5-min Apgar score
·3 and babies with at least one major morbidity had sig-
niWcantly independent eVects on 7-day (OR 13, 95% CI
2.6–66; OR 11.9, 95% CI 1.3–106.7) and 28-day/discharge
survival (OR 10.2, 95% CI 2.1–50.8; OR 8.1, 95% CI 1.4–
45.7). However, multiple pregnancy and gestational age
<26 weeks were the only two independent risk factors for
survival with at least one major morbidity on 24-h (OR 5.9,
95% CI 2.1–16.4; OR 7.9, 95% CI 3.0–21.2), 7-day (OR
3.9, 95% 1.3–11.6; OR 7.7, 95% CI 2.8–21.4) and 28-day/
discharge survival (OR 5.2, 95%CI 1.6–17.0; OR 9.5, 95%
CI 3.2–28.6).
Discussion
Estimates of survival and morbidity of extreme prematurity
ranged widely, partially because of diVerences in criteria
for selection and in measures of outcomes, in organization
of care, in attitude towards resuscitation and life support. In
addition, most of the studies were based on a small number
of extremely premature newborns. Synnes et al. [10]
studied infants born at 23–28 weeks of gestation from 1983
to 1989 in 1,024 births and showed that gestational age
Table 3 Relation between neonatal survival and maternal, obstetric and neonatal characteristics in univariate analysis
Values are expressed in % (no.)
pPROM preterm premature rupture of membranes, IUGR intrauterine growth restriction
24-h 7-day 28-day/discharge
Alive Dead P Alive Dead P Alive Dead P
Maternal age ¸35 years 29.4 (30) 57.1 (4) 0.126 30.4 (28) 35.3 (6) 0.691 28.4 (25) 42.9 (9) 0.199
Nulliparous 56.9 (58) 42.9 (3) 0.47 58.7 (54) 41.2 (7) 0.18 60.2 (53) 38.1 (8) 0.066
Pregestational disease 19.6 (20) 14.3 (1) 0.73 18.5 (17) 23.5 (4) 0.628 19.3 (17) 19 (4) 0.977
Pre-eclampsia 18.6 (19) 28.6 (2) 0.519 19.6 (18) 17.3 (3) 0.854 20.5 (18) 14.3 (3) 0.52
Antepartum haemorrhage 16.7 (17) 28.6 (2) 0.422 16.3 (15) 23.5 (4) 0.471 17 (15) 19 (4) 0.828
pPROM 23.5 (24) 42.9 (3) 0.252 25 (23) 23.5 (4) 0.897 26.1 (23) 19 (4) 0.499
Cervical insuYciency 15.7 (16) 0 (0) 0.257 12 (11) 29.4 (5) 0.062 11.4 (10) 28.6 (6) 0.045
Oligohydramnion 4.9 (5) 14.4 (1) 0.292 5.4 (5) 5.9 (1) 0.941 5.7 (5) 4.8 (1) 0.868
Chorioamnionitis 21.6 (22) 28.6 (2) 0.665 20.7 (19) 29.4 (5) 0.423 20.5 (18) 28.6 (6) 0.42
Placental abruption 9.8 (10) 14.3 (1) 0.703 8.7 (8) 17.6 (3) 0.26 9.1 (8) 14.3 (3) 0.478
IUGR 18.6 (19) 0 (0) 0.209 18.5 (17) 11.8 (2) 0.503 17 (15) 19 (4) 0.828
Gestational age <26 weeks 38.2 (39) 85.7 (6) 0.014 34.8 (32) 76.5 (13) 0.001 35.2 (31) 66.7 (14) 0.009
Multiple pregnancy 67.7 (69) 71.4 (5) 0.836 72.8 (67) 41.2 (7) 0.01 73.9 (65) 42.9 (9) 0.006
Caesarean section 62.7 (64) 42.9 (3) 0.536 60.9 (56) 64.7 (11) 0.883 60.2 (53) 66.7 (14) 0.787
Male infants 51 (52) 85.7 (6) 0.075 50 (46) 70.6 (12) 0.118 48.9 (43) 71.4 (15) 0.063
Birth weight <800 g 46.1 (47) 85.7 (6) 0.042 43.5 (40) 76.5 (13) 0.012 42 (37) 76.2 (16) 0.005
Apgar score ·3 at 5 min 4.9 (5) 85.7 (6) <0.005 4.3 (4) 41.2 (7) <0.005 4.5 (4) 33.3 (7) <0.005
At least one major morbidity 43.1 (44) 100 (7) 0.004 38 (35) 94.1 (16) <0.005 36.4 (32) 90.5 (19) <0.005Arch Gynecol Obstet (2011) 284:1381–1387 1385
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(GA)-speciWc mortality rates decreased with increasing
GA. The mortality rate was 84% at 23 weeks, 57% at
24 weeks, 45% at 25 weeks, 37% at 26 weeks, 23% at
27 weeks and 13% at 28 weeks GA. In a large Norwegian
cohort study [5] including 903,402 infants without congeni-
tal anomalies born alive between 1967 and 1983 and
followed through 2003, survival rates were only 17.8% at
23–27 weeks of gestation. In a recent review of data avail-
able in 2007 [11], survival Wgures for live births from a
number of large, population-based cohort studies on prema-
ture births between 1990 and 1997 were summarized. At
24 weeks gestation, mean survival ranged from 16 to 44%,
corresponding Wgures were 33–64% at 25 weeks, 54–68%
at 26 weeks and 68–85% at 27 weeks, respectively.
A Norwegian nationally based cohort study [12] investi-
gated all infants with a gestational age 22–27 completed
weeks or a birth weight 500–999 g who were born in
Norway in 1999 and 2000. It reported the survival rates for
all infants admitted to NICU of 60% for 24 weeks, 80%
for 25 weeks, 84% for 26 weeks and 93% for 27 weeks,
respectively. In our study, the neonatal survival rate was
higher compared with previous studies [5, 10] and those
survival data reviewed in 2007 [11], but was consistent
with the Norwegian population-based study [12]. Perinatal
care has changed dramatically over the past 20 years. New
treatment strategies including antenatal steroid therapy and
surfactant administration have contributed in preventing mor-
tality and morbidity of extremely preterm infants [13, 14].
The two previous studies mentioned before [5, 10] included
premature births before 1990, where antenatal steroid ther-
apy and surfactant administration were not available. How-
ever, administration of antenatal steroid was a standard
treatment in our study population. This may partially
explain why neonatal survival in our study is higher than
the two previous studies.
None of the pregestational maternal diseases, obstetric
complications and mode of delivery proved to be a signiW-
cant risk factor of neonatal mortality of extreme prematu-
rity in the present study, which was inconsistent with some
previous studies [15, 16], but in accordance with others
[8, 17]. A 5-min Apgar score ·3 and infants with at least
one major morbidity were the only two independent predic-
tors of neonatal mortality at 7 and 28 days postpartum/dis-
charge in the present study. A Low 5-min Apgar score has
previously been reported as a predictor of neonatal mortal-
ity. Locatelli et al. [18] showed that small for gestational
age and birth weight, female gender, low 5-min Apgar
score and failure of steroid administration were indepen-
dent predictors of survival in infants weighing 750 g or
less. Cumulatively, these Wve predictors explained 69% of
neonatal survival. A recent study from India [16] showed
common antenatal and perinatal predictors of mortality in
Table 4 Relation between neonatal survival with at least one major morbidity and maternal, obstetric and neonatal characteristics in univariate
analysis
Values are expressed in % (no.)
pPROM preterm premature rupture of membranes, IUGR intrauterine growth restriction
24-h 7-day 28-day/discharge
Yes No P Yes No P Yes No P
Maternal age ¸35 years 36.2 (16) 24.1 (14) 0.18 42.9 (15) 22.8 (13) 0.042 37.5 (12) 23.2 (13) 0.153
Nulliparous 50 (22) 62.1 (36) 0.223 54.3 (19) 61.4 (35) 0.501 59.4 (19) 40.6 (13) 0.902
Pregestational disease 20.5 (9) 19 (11) 0.851 17.1 (6) 19.3 (11) 0.796 18.8 (6) 19.6 (11) 0.919
Pre-eclampsia 15.9 (7) 20.7 (12) 0.539 20 (7) 19.3 (11) 0.934 21.9 (7) 19.6 (11) 0.803
Antepartum haemorrage 11.4 (5) 20.7 (12) 0.211 8.6 (3) 21.1 (12) 0.116 9.4 (3) 21.4 (12) 0.148
pPROM 15.9 (7) 29.3 (17) 0.114 20 (7) 28.1 (16) 0.385 21.9 (7) 28.6 (16) 0.492
Cervical insuYciency 22.7 (10) 10.3 (6) 0.89 14.3 (5) 10.5 (6) 0.589 12.5 (4) 10.7 (6) 0.8
Oligohydramnion 4.5 (2) 5.2 (3) 0.885 5.7 (2) 5.3 (3) 0.926 6.2 (2) 5.4 (3) 0.862
Chorioamnionitis 15.9 (7) 25.9 (15) 0.226 11.4 (4) 26.3 (15) 0.087 9.4 (3) 26.8 (15) 0.051
Placental abruption 9.1 (4) 10.3 (6) 0.833 5.7 (2) 10.5 (6) 0.426 6.3 (2) 10.7 (6) 0.483
IUGR 15.9 (7) 20.7 (12) 0.539 17.1 (6) 19.3 (11) 0.796 15.6 (5) 17.9 (10) 0.789
Gestational age <26 weeks 61.4 (27) 20.7 (12) <0.005 20 (21) 19.3 (11) <0.005 62.5 (20) 19.6 (11) <0.005
Multiple pregnancy 50 (22) 19 (11) 0.001 40 (14) 19.3 (11) 0.03 40.6 (13) 17.9 (10) 0.019
Caesarean section 63.6 (28) 62.1 (36) 0.681 60 (21) 61.4 (35) 0.713 59.4 (19) 60.7 (34) 0.73
Male infants 54.5 (24) 48.3 (28) 0.53 54.3 (19) 47.3 (27) 0.519 53.1 (17) 46.4 (26) 0.545
Birth weight <800 g 61.4 (27) 34.5 (20) 0.007 60 (21) 33.3 (19) 0.012 59.4 (19) 32.1 (18) 0.013
Apgar score ·3 at 5 min 6.8 (3) 3.4 (2) 0.435 5.7 (2) 3.5 (2) 0.615 6.2 (2) 3.6 (2) 0.5621386 Arch Gynecol Obstet (2011) 284:1381–1387
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VLBW infants (500–1,500 g and >26 weeks’ gestations),
including maternal bleeding, failure to administer antenatal
steroids, low Apgar score, apnoea, extreme prematurity,
neonatal septicaemia and shock. Previous studies showed
that chorioamnionitis was not only signiWcantly associated
with higher short-term but also higher long-term major
morbidity of immature neonates, such as intraventricular
haemorrhage, bronchopulmonary dysplasia and necrotizing
enterocolitis, cerebral palsy and early childhood asthma
[15, 19, 20]. In the present study, clinical chorioamnionitis
only showed an increased trend towards neonatal morbidity
in the univariate analysis, a factor which could have been
inXuenced by the small number of subjects. A large sam-
pling would improve the precision of estimates of chorio-
amnionitis on the outcome of extremely premature infants.
Results of studies on survival of preterm twins, by com-
parison with preterm singletons matched for gestational
age, are conXicting. Some studies showed that extremely
premature twins do not suVer more deaths than singletons
[21, 22], while others have shown an increased mortality
compared with singletons [10, 23]. A recent population-
based study on mortality of twin and singleton live births
under 30 weeks’ gestation [24] showed that the increased
mortality among twins of less than 30 weeks’ gestation
between 1998 and 2001 was conWned to 25 weeks or less
than singletons. However, there appeared to be no excess
mortality in twin neonates less than 30 weeks’ gestation
when compared with singletons delivered between 2002
and 2005. This is consistent with our Wndings based on the
data 2004–2007 that extremely prematurity multiple infants
appeared to have no excess neonatal mortality than
singletons.
There was a trend in the obstetric management of pre-
term labour in the direction of more active policies with
caesarean section to avoid traumatic and asphyxial damage
to the baby. Solum [25] suggested that caesarean section
might be used liberally due to the fragility of the immature
fetus and any kind of birth trauma should be minimized.
When complicated by breech presentation, delivery seems
to be best performed by the abdominal route. The guide-
lines of our institution state that premature fetuses between
25 and 34 weeks’ gestation complicated by breech presen-
tation should be delivered by caesarean section. There are
conXicting data regarding the outcome of caesarean section
in delivering extremely premature infants before 26 weeks’
gestation. Some studies showed that caesarean section was
associated with improved neonatal survival and morbidity
[4, 26], while others failed to show any survival beneWt [17,
27]. Mukhopadhyay et al. [27] showed that the survival
rates for newborns delivered by caesarean section for fetal
reasons before 26 weeks is very poor and suggested that
caesarean section before 26 weeks should therefore be per-
formed predominantly for maternal reasons only. In the
present study, caesarean section showed neither survival
nor morbidity beneWt for these extremely premature infants.
Among the four infants at 24 weeks’ gestation who were
delivered by caesarean section, there was one triplet preg-
nancy where all infants died before 7-day postpartum. The
one survivor was a singleton with 5-min Apgar score of 9
which still suVered from both periventricular leukomalacia
and bronchopulmonary dysplasia. Indeed, preterm caesar-
ean section is technically diYcult and does sometimes
require vertical lower segment incision with possible
adverse consequences on future pregnancy. Maternal
co-morbid and life-threatening conditions further complicate
the issue. Excess morbidity was observed among survivors
of extremely premature multiple infants and babies that
were delivered before 26 weeks of gestation in the present
study. Therefore, oVering caesarean section deliveries to
infants before 26 weeks of gestation, especially to multiple
infants, should be carefully judged against the short- and
long-term neonatal outcome.
ConXicts of interest between parents facing the risk of a
handicapped child and/or between parents and society are
likely to be encountered in cases of extreme prematurity,
thus making it essential for the medical staV to give prefer-
ence to the patient’s best interests. In a New South Wales
and Australian Capital Territory multidisciplinary work-
shop with consumers’ and parents’ participation and
extended consultations [28], there were consensus that
there was an increasing obligation to treat cases involving
between 23+0 and 25+6 weeks of gestation, while it was
acceptable not to initiate intensive care following appropri-
ate counselling with the parents. In Norway, the gestational
age limit for oVering resuscitation should be 23–25 com-
pleted weeks and within this range an individual approach
is appropriate (Norwegian Research Council 1999).
Although the present study showed that gestational age was
not a signiWcant predictor of neonatal mortality of
extremely premature newborns, an excess morbidity rate
among infants who were delivered before 26 weeks of
gestation and among multiple infants was observed. The
present study highlights that decisions about obstetric
management and resuscitation of extremely preterm infants
should be a collaborative process combining multidisciplin-
ary team management and the wishes of parents before/
during labour and after delivery, especially for multiple
infants and babies who were delivered before 26 weeks of
gestation.
The strength of our study is that high-quality medical
care is readily accessible to all extremely premature live
births, which assures a degree of uniformity of manage-
ment. However, a retrospective study such as our study also
has several limitations. First, as suggested above, it has the
attendant limitations of a hospital-based study with a possi-
ble risk of selection bias. Second, it failed to adjust for allArch Gynecol Obstet (2011) 284:1381–1387 1387
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confounding/intermediate variables, which may aVect perinatal
outcomes of extremely premature infants but are not
commonly collected in the administrative database, such as
rates, smoking practices and alcohol exposure. Another
weakness was the small number of subjects included in the
study; a large sampling would improve the precision of
estimates of outcome. Hence some of our results require a
rather cautious interpretation.
Conclusions
Neonatal survival was signiWcantly predicted by a 5-min
Apgar score and neonatal morbidity, independent of
pregestational maternal disease, obstetric complications,
method of delivery, gestational age and birth weight in
extreme preterm deliveries. The excess morbidity rate was
conWned among multiples and babies who were delivered
before 26 weeks of gestation.
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